← FDA Drug Approvals (Drugs@FDA)
TECENTRIQ HYBREZA
BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2024-09-12
Drug application
- FDA Application #
BLA761347- Application type
- Biologics License Application
- Brand name
- TECENTRIQ HYBREZA
- Generic name
- ATEZOLIZUMAB AND HYALURONIDASE-TQJS
- Active ingredients
- ATEZOLIZUMAB AND HYALURONIDASE-TQJS
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- GENENTECH INC
- Manufacturer
- Genentech, Inc.
- First approval
- 2024-09-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown